Chen, Xin
Fudan University Shanghai Cancer Center
7 papers on CoChatORCID 0000-0002-5208-2154
Most cited papers
- Verified
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer
Duncan, J. S., Whittle, M. C., Nakamura, K., Abell, A. N., Midland, A. A., Zawistowski, J. S., Johnson, N. L., Granger, D. A., Jordan, N. V., Darr, D. B., et al. (2012) · Cell
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 732
- Verified
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons
Huang, H.-S., Allen, J. A., Mabb, A. M., King, I. F., Miriyala, J., Taylor-Blake, B., Sciaky, N., Dutton, J. W., Lee, H.-M., Chen, X., et al. (2012) · Nature
Genetic Syndromes and ImprintingGenetics and Neurodevelopmental Disorders
Cited by 387
- Verified
Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65
Huang, X.-P., Karpiak, J., Kroeze, W. K., Zhu, H., Chen, X., Moy, S. S., Saddoris, K. A., Nikolova, V. D., Farrell, M. S., Wang, S., et al. (2015) · Nature
Receptor Mechanisms and SignalingComputational Drug Discovery Methods
Cited by 284
- Verified
Neuroprotective Natural Products for Alzheimer’s Disease
Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells
Medicinal Plants and NeuroprotectionAlzheimer's disease research and treatments
Cited by 236
- Verified
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex
Zawistowski, J. S., Bevill, S. M., Goulet, D. R., Stuhlmiller, T. J., Beltran, A. S., Olivares-Quintero, J. F., Singh, D., Sciaky, N., Parker, J. S., Rashid, N. U., et al. (2017) · Cancer Discovery
Melanoma and MAPK PathwaysChromatin Remodeling and Cancer
Cited by 180
- Verified
A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples
Chen, W., Zhao, Y., Chen, X., Yang, Z., Xu, X., Bi, Y., Chen, V., Li, J., Choi, H., Ernest, B., et al. (2021) · Nature Biotechnology
Single-cell and spatial transcriptomicsGene expression and cancer classification
Cited by 114
- Verified
An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
Feng, M., Cui, H., Tu, W., Li, L., Gao, Y., Chen, L., Li, D., Chen, X., Xu, F., Zhou, C., et al. (2022) · Frontiers in Genetics
Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics
Cited by 37
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free